2Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy collaborative group:Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl J Med,2001,345:1368-1377.
3Hotchkiss RS,Karl JE.The pathophysiology and treatment of sepsis.N Eng J Med,2003,348:138-150.
4Kox WJ,Bone DC,Krausch D,et al.Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome.A new approach:proof of principle.Arch Intern Med,1997,157:389-393.
5Annane D,Sebille V,Charpentier C,et al.Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock,JAMA,2002,288:862-971.
6Cronin L,Cook DJ,Carlet J,et al.Corticosteroid treatment for sepsis:a critical appraisal and meta-analysis of the literature.Crit Care Med,1995,23:1430-1439.
7Fakhry SM.Hematologic principles in surgery.In:Sabiston,eds.Textbook of surgery.Philadelphia:WB Saunders Company,2001.68.
8Dellinger RP.Surviving sepsis campaign gideline for management of severe sepsis and septic shock.Crit Care Med,2004,32:858-873.
9Doctor A,Arnold J.Mechanical support of lung injury:Opitons for strategic ventilation.New Horiz,1999,7:359-373.
10Van den berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in the critically ill patients.N Engl J Med,2001,345:1359-1367.
二级参考文献7
1Lena M. Jonge ED, Poll TVD Rationale for physiological anticoagulant pathways in patients with sepsis and disseminated intravascutar coagulation. Crit Care Med,2001; 29 (7): S90.
2Marshall JC.Inflanunation.coagulopathy.and the pathogenesis of muliple organ dysfunction syndrome.Crit Care Med.2001.29(7):S99.
3Bernard G, Vincent J Laterre P, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Eng J Med, 2001; 344: 699.
4Gando S. Disseminated Intravascular Coagulation in Trauma Patients. Semin Thromb Hemost 2001; 27: 585.
5Hardaway RM, Williams CH, Vasquez Y. Disseminated Intravascular Coagulation in Sepsis. Semin Thromb Hemost 2001; 27: 577.
6Levi M, Joage ED, Poll TVD, et al. Advances in The Understanding of the Pathogentic Patbways o f Disseminated Intravascular Coagulation Result in More Insight in the Clinical Picture and Better Management Strategies. Semin Thromb Hemost 2001; 27: 569.
7Fareed J, Hoppensteadt DA, Bick RL. An Update on Hepatitis at the Beginning of the New Millennium. Semin Thromb Hemost 2000; 26: 5.
